ArticleBlood research2022

High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea.

Jee Hyun Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.